Skip to content

Public FDA record

Z-0738-2020: STA SYSTEM CONROL N + P (ref. 00678)

Recall record Z-0738-2020 for Diagnostica Stago, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0738-2020
Company in FDA record
Diagnostica Stago, Inc.
FDA classification date
Dec 23, 2019
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

A positive bias was confirmed to exists on the STA - Unicalibrator levels with STA - Deficient IX and STA - Deficient VIII when compared to the International Standard (IS) for factor VIII or IX. This bias is also observed on several External Quality Assessment (EQA) results.

Source facts

Action
On November 18, 2019 the firm distributed Urgent Medical Device Recall Communication letters by mail stating: FIELD SAFETY NOTICE Combined use of the following reagents STA UNICALIBRATOR (ref. 00675) and STA DEFICIENT VIII (ref. 00725) STA DEFICIENT IX (ref. 00724) Dear Customer, You are using the STA Unicalibrator (00675) and STA Deficient VIII (00725) and/or STA Deficient IX (00724) and according to our records, you have ordered and received in your laboratory one or several kits of the STA - Unicalibrator listed in Appendix 1. Following the identification of a defect, please see the information below about the reagents and lots listed in Appendix 1. Description: Following a customer complaint, Stago has investigated and confirmed a positive bias on some STA - Unicalibrator levels. These high levels affect tests using STA - Deficient IX and STA - Deficient VIII reagents. Stago has accordingly reduced the concerned Unicalibrator plasma levels (see new levels on the attached lot-specific barcode sheets). According to our internal testing results, the reduced Unicalibrator plasma levels result in a decrease of Factor VIII and IX results on normal and below-normal patient plasmas. This change has no impact on the classification of hemophiliac patients (type A or B) as severe, moderate or mild. The reassignment of the Unicalibrator plasma levels necessitated a change in the acceptance ranges on the corresponding Quality Control plasmas for Factor VIII and IX parameters with the STA - Deficient VIII and IX reagents. You will find new barcode sheets for each lot of the affected reagents in the attachments. Actions: Upon receipt of this letter, we kindly ask you to: - No longer use the values indicated for STA - Deficient VIII and IX reagents on the barcode sheets in your possession (for the reagents & lots listed in Appendix 1). - Use the new barcode sheets (attached): - For STA - Unicalibrator: Use the analyzer-spec
Initiated
2019-11-18
Root cause
Process control
Terminated
2023-01-12
Distribution
US: MA ME VT CT NJ NY PA DC MD VA NC SC GA FL AL TN MS KY OH IN MI IA WI MN SD ND MT IL MO KS LA AR OK TX CO AZ NV CA HI OR WA AK
Recall number
Z-0738-2020
Recall status
Terminated
CDRH record ID
178245
FDA classified
2019-12-23
Recall event number
84402

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗